EN HU

Tósaki Árpád

Publication list

Uploaded publications:
192
Publications in DEA:
191
OA:
44
Date range:
1984-2026
2026
1.
Szabó, E., Király, J., Mondal, A. B., Bereczki, I., Szabó, Z., Tósaki, Á.: BM-164 (an H2S-donor) modulates microRNA expression associated with reperfusion-induced ventricular fibrillation in rat hearts.
Eur. J. Pharm. Sci. 218, 1-12, (article identifier: 107433), 2026.
Journal metrics:
Q1 Pharmaceutical Science (2024)
2025
2.
Haines, D. D., Rose, S. C., Cowan, F. M., Mahmoud, F. F., Rizvanov, A. A., Tósaki, Á.: Leveraging Artificial Intelligence and Modulation of Oxidative Stressors to Enhance Healthspan and Radical Longevity.
Biomolecules. 15 (11), 1-28, (article identifier: 1501), 2025.
Journal metrics:
Q1 Biochemistry (2024)
Q2 Molecular Biology (2024)
2024
3.
Tósaki, Á., Szabó, Z., Király, J., Lőrincz, E. B., Vass, V., Tánczos, B., Bereczki, I., Herczegh, P., Remenyik, É., Tósaki, Á., Szabó, E.: A new cannabigerol derivative, LE-127/2, induces autophagy mediated cell death in human cutaneous melanoma cells.
Eur. J. Pharm. Sci. 203, 1-15, (article identifier: 106920), 2024.
Journal metrics:
Q1 Pharmaceutical Science
4.
Tánczos, B., Vass, V., Szabó, E., Lovas, M., Kattoub, R. G., Bereczki, I., Borbás, A., Herczegh, P., Tósaki, Á.: Effects of H2S-donor ascorbic acid derivative and ischemia/reperfusion-induced injury in isolated rat hearts.
Eur. J. Pharm. Sci. 195, 1-15, (article identifier: 106721), 2024.
Journal metrics:
Q1 Pharmaceutical Science
5.
Haines, D. D., Cowan, F. M., Tósaki, Á.: Evolving Strategies for Use of Phytochemicals in Prevention and Long-Term Management of Cardiovascular Diseases (CVD).
Int. J. Mol. Sci. 25 (11), 1-25, (article identifier: 6176), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2023
6.
Szőke, K., Bódi, B., Hendrik, Z., Czompa, A., Gyöngyösi, A., Haines, D. D., Papp, Z., Tósaki, Á., Lekli, I.: Rapamycin treatment increases survival, autophagy biomarkers and expression of the anti-aging klotho protein in elderly mice.
Pharmacol. Res. & Perspec. 11 (3), 1-11, (article identifier: 01091), 2023.
Journal metrics:
Q2 Neurology
Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
7.
Vass, V., Szabó, E., Bereczki, I., Debreczeni, N., Borbás, A., Herczegh, P., Tósaki, Á.: Reperfusion-induced injury and the effects of the dithioacetate type hydrogen sulfide donor ibuprofen derivative, BM-88, in isolated rat hearts.
Eur. J. Pharm. Sci. 185, 1-14, (article identifier: 106449), 2023.
Journal metrics:
Q1 Pharmaceutical Science
2022
8.
Csépányi, E., Gyöngyösi, A., Lekli, I., Tósaki, Á., Bak, I.: Beta-Carotene Affects the Effects of Heme Oxygenase-1 in Isolated, Ischemic/Reperfused Rat Hearts: potential Role of the Iron.
Molecules. 27 (9), 1-12, (article identifier: 3039), 2022.
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
2021
9.
Gyöngyösi, A., Verner, V., Bereczki, I., Kiss-Szikszai, A., Zilinyi, R., Tósaki, Á., Bak, I., Borbás, A., Herczegh, P., Lekli, I.: Basic Pharmacological Characterization of EV-34, a New H2S-Releasing Ibuprofen Derivative.
Molecules. 26 (3), 1-12, 2021.
Journal metrics:
Q2 Analytical Chemistry
Q2 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
2020
10.
Tósaki, Á.: ArrhythmoGenoPharmacoTherapy.
Front. Pharmacol. 11, 1-19, (article identifier: 616), 2020.
Journal metrics:
Q1 Pharmacology
Q1 Pharmacology (medical)
11.
Haines, D. D., Tósaki, Á.: Heme Degradation in Pathophysiology of and Countermeasures to Inflammation-Associated Disease.
Int. J. Mol. Sci. 21 (24), 1-25, (article identifier: 9698), 2020.
Journal metrics:
Q2 Catalysis
D1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
D1 Physical and Theoretical Chemistry
D1 Spectroscopy
2019
12.
Szőke, K., Czompa, A., Lekli, I., Szabados-Fürjesi, P., Herczeg, M., Csávás, M., Borbás, A., Herczegh, P., Tósaki, Á.: A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety.
Eur. J. Pharm. Sci. 131, 159-166, 2019.
Journal metrics:
Q1 Pharmaceutical Science
13.
Szőke, K., Czompa, A., Lekli, I., Szabados-Fürjesi, P., Herczeg, M., Csávás, M., Borbás, A., Herczegh, P., Tósaki, Á.: Dataset on structure, stability and myocardial effects of a new hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety.
Data brief. 25, 1-10, (article identifier: 104146), 2019.
Journal metrics:
Q4 Education
Q4 Multidisciplinary
14.
Czeglédi, A., Tósaki, Á., Gyöngyösi, A., Zilinyi, R., Tósaki, Á., Lekli, I.: Electrically-Induced Ventricular Fibrillation Alters Cardiovascular Function and Expression of Apoptotic and Autophagic Proteins in Rat Hearts.
Int. J. Mol. Sci. 20 (7), 1-12, (article identifier: 1628), 2019.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
Q1 Spectroscopy
15.
Gyöngyösi, A., Szőke, K., Fenyvesi, F., Fejes, Z., Bekéné Debreceni, I., Nagy, B. J., Tósaki, Á., Lekli, I.: Inhibited autophagy may contribute to heme toxicity in cardiomyoblast cells.
Biochem. Biophys. Res. Commun. 511 (4), 732-738, 2019.
Journal metrics:
Q2 Biochemistry
Q1 Biophysics
Q3 Cell Biology
Q3 Molecular Biology
16.
Gyöngyösi, A., Zilinyi, R., Czeglédi, A., Tósaki, Á., Tósaki, Á., Lekli, I.: The role of autophagy and death pathways in dose-dependent isoproterenol-induced cardiotoxicity.
Curr. Pharm. Design. 25 (19), 2192-2198, 2019.
Journal metrics:
Q2 Drug Discovery
Q2 Pharmacology
2018
17.
Czompa, A., Szőke, K., Prokisch, J., Gyöngyösi, A., Bak, I., Balla, G., Tósaki, Á., Lekli, I.: Aged (Black) versus Raw Garlic against Ischemia/Reperfusion-Induced Cardiac Complications.
Int. J. Mol. Sci. 19 (4), 1-13, (article identifier: 1017), 2018.
Journal metrics:
Q1 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
Q1 Spectroscopy
18.
Haines, D. D., Tósaki, Á.: Emerging Clinical Applications of Heme Oxygenase.
Curr. Pharm. Design. 24 (20), 2227-2228, 2018.
19.
Barta, T., Tósaki, Á., Haines, D. D., Balla, G., Lekli, I., Tósaki, Á.: Endothelin-1-induced hypertrophic alterations and heme oxygenase-1 expression in cardiomyoblasts are counteracted by beta estradiol: in vitro and in vivo studies.
Naunyn-Schmiedebergs Arch. Pharmacol. 391 (4), 371-383, 2018.
Journal metrics:
Q2 Medicine (miscellaneous)
Q2 Pharmacology
20.
Haines, D. D., Tósaki, Á.: Role of Heme Oxygenases in Cardiovascular Syndromes and Co-morbidities.
Curr. Pharm. Design. 24 (20), 2322-2325, 2018.
Journal metrics:
Q2 Drug Discovery
Q2 Pharmacology
21.
Szabados-Fürjesi, P., Pajtás, D., Barta, A., Csépányi, E., Kiss-Szikszai, A., Tósaki, Á., Bak, I.: Synthesis, in Vitro Biological Evaluation, and Oxidative Transformation of New Flavonol Derivatives: The Possible Role of the Phenyl-N,N-Dimethylamino Group.
Molecules. 23 (12), 1-15, (article identifier: 3161), 2018.
Journal metrics:
Q2 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
22.
Zilinyi, R., Czompa, A., Czeglédi, A., Gajtkó, A., Pituk, D., Lekli, I., Tósaki, Á.: The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: the Role of Autophagy.
Molecules. 23 (5), 1-12, (article identifier: 1184), 2018.
Journal metrics:
Q2 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q3 Molecular Medicine
Q2 Organic Chemistry
Q1 Pharmaceutical Science
Q2 Physical and Theoretical Chemistry
23.
Csépányi, E., Czompa, A., Szabados-Fürjesi, P., Lekli, I., Balla, J., Balla, G., Tósaki, Á., Bak, I.: The Effects of Long-Term, Low- and High-Dose Beta-Carotene Treatment in Zucker Diabetic Fatty Rats: the Role of HO-1.
Int. J. Mol. Sci. 19 (4), 1-13, (article identifier: 1132), 2018.
Journal metrics:
Q1 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
Q1 Spectroscopy
24.
Gyöngyösi, A., Terraneo, L., Bianciardi, P., Tósaki, Á., Lekli, I., Samaja, M.: The Impact of Moderate Chronic Hypoxia and Hyperoxia on the Level of Apoptotic and Autophagic Proteins in Myocardial Tissue.
Oxidative Medicine and Cellular Longevity. 2018, 1-12, 2018.
Journal metrics:
Q2 Aging
Q1 Biochemistry
Q2 Cell Biology
Q1 Medicine (miscellaneous)
2017
25.
Vecsernyés, M., Szokol, M., Bombicz, M., Priksz, D., Gesztelyi, R., Fülöp, G. Á., Varga, B., Juhász, B., Haines, D. D., Tósaki, Á.: Alpha-Melanocyte-stimulating Hormone Induces Vasodilation and Exerts Cardioprotection Through the Heme-Oxygenase Pathway in Rat Hearts.
J. Cardiovasc. Pharmacol. 69 (5), 286-297, 2017.
Journal metrics:
Q2 Cardiology and Cardiovascular Medicine
Q2 Pharmacology
DEENK University of Debrecen
© 2012 University of Debrecen